AXL Is a Logical Molecular Target in Head and Neck Squamous Cell Carcinoma.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
Toni M BrandDeric L Wheeler

Abstract

Head and neck squamous cell carcinoma (HNSCC) represents the eighth most common malignancy worldwide. Standard-of-care treatments for patients with HNSCC include surgery, radiation, and chemotherapy. In addition, the anti-EGFR monoclonal antibody cetuximab is often used in combination with these treatment modalities. Despite clinical success with these therapeutics, HNSCC remains a difficult malignancy to treat. Thus, identification of new molecular targets is critical. In the current study, the receptor tyrosine kinase AXL was investigated as a molecular target in HNSCC using established cell lines, HNSCC patient-derived xenografts (PDX), and human tumors. HNSCC dependency on AXL was evaluated with both anti-AXL siRNAs and the small-molecule AXL inhibitor R428. Furthermore, AXL inhibition was evaluated with standard-of-care treatment regimens used in HNSCC. AXL was found to be highly overexpressed in several models of HNSCC, where AXL was significantly associated with higher pathologic grade, presence of distant metastases, and shorter relapse-free survival in patients with HNSCC. Further investigations indicated that HNSCC cells were reliant on AXL for cellular proliferation, migration, and invasion. In addition, targeting AX...Continue Reading

References

May 4, 2000·Journal of the National Cancer Institute·M L GillisonD Sidransky
Aug 30, 2003·Oncogene·Rupert K Schmidt-UllrichPeck-Sun Lin
Jun 17, 2005·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J B Vermorken
Dec 16, 2005·Neoplasia : an International Journal for Oncology Research·Yi-Shing ShiehCheng-Wen Wu
Feb 10, 2006·The New England Journal of Medicine·James A BonnerK Kian Ang
Sep 9, 2006·Proceedings of the National Academy of Sciences of the United States of America·Katerina StratiPaul F Lambert
Mar 15, 2008·Cancer Research·Yi-Xiang ZhangAxel Ullrich
Jul 16, 2008·Advances in Cancer Research·Rachel M A LingerDouglas K Graham
Sep 12, 2008·The New England Journal of Medicine·Jan B VermorkenRicardo Hitt
Jul 21, 2009·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Raymond E MeynK Kian Ang
Sep 1, 2009·Otolaryngology--head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery·Paul M WeinbergerAmanda Psyrri
Aug 11, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Danny RischinGrant A McArthur
Sep 23, 2010·Cancer Research·Erinn B RankinAmato J Giaccia
Oct 15, 2010·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J B Vermorken, P Specenier
Feb 24, 2011·Cancer Research·Elvira AvillaRosa Marina Melillo
Feb 26, 2011·International Journal of Cancer. Journal International Du Cancer·Jacques FerlayDonald Maxwell Parkin
Jul 4, 2012·Nature Genetics·Zhenfeng ZhangTrever G Bivona
Oct 24, 2012·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Lauren Averett ByersJohn V Heymach
Dec 20, 2012·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Randall J KimplePaul F Lambert
May 21, 2013·Biochemical and Biophysical Research Communications·Ju HanTingsheng Peng
Oct 31, 2013·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Philip D DunneSandra Van Schaeybroeck
Mar 4, 2014·Physics in Medicine and Biology·Tyler L FowlerBryan P Bednarz
Jun 7, 2014·Journal of Clinical Pathology·Timothy M D'AlfonsoSandra J Shin
Aug 12, 2014·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Ann Marie EgloffArlene A Forastiere
Aug 16, 2014·Cancer Research·Catherine WilsonJeff Settleman
Aug 20, 2014·Cancer Research·Toni M BrandDeric L Wheeler
Aug 21, 2014·Molecular Cancer Therapeutics·Clémence FeneyrollesAziz Yasri

❮ Previous
Next ❯

Citations

Dec 28, 2016·International Journal of Molecular Sciences·Anne von MässenhausenSven Perner
Jan 11, 2017·British Journal of Cancer·Carl M GayLauren Averett Byers
Mar 9, 2017·Scientific Reports·Stanley G KimaniRaymond B Birge
Aug 6, 2017·International Journal of Cancer. Journal International Du Cancer·Ilyes BeraniaApostolos Christopoulos
Feb 20, 2018·Molecular Cancer·Manoj Kumar Kashyap, Omar Abdel-Rahman
Feb 26, 2019·Current Pharmaceutical Design·Pranathi TataKiran Kalia
Jun 10, 2017·World Journal of Gastroenterology : WJG·Wael M Abdel-RahmanMaha Saber-Ayad
Oct 21, 2016·MedChemComm·Bibiana I FerreiraJames B Lorens
Jan 25, 2017·Oncotarget·Ghada Abboud-JarrousTal Burstyn-Cohen
Jul 17, 2019·Cell Death & Disease·Elham AlsahafiMahvash Tavassoli
Mar 6, 2017·Oncology Reports·Yun Jung ChoiJae Cheol Lee
Jul 2, 2020·OncoTargets and Therapy·Lirui HeGuoqing Lv
Nov 12, 2016·Cancers·Erinn B Rankin, Amato J Giaccia
Nov 5, 2016·Journal of Cancer Research and Clinical Oncology·Omid ZareiSiavoush Dastmalchi
Nov 5, 2019·Frontiers in Oncology·Emily N ArnerRolf A Brekken
Mar 3, 2020·Frontiers in Chemistry·Edita SarukhanyanThomas Dandekar
Feb 1, 2019·Experimental & Molecular Medicine·Hyung Kwon ByeonJaemoon Yang
Sep 7, 2019·Cancer Immunology Research·Stéphane TerrySalem Chouaib
Jul 17, 2016·Molecular Cancer Therapeutics·Mari IidaDeric L Wheeler
Sep 28, 2016·Molecular Cancer Research : MCR·Kavitha BalajiKhandan Keyomarsi
Dec 25, 2019·Molecular Cancer Therapeutics·Karine Flem-KarlsenVivi Ann Flørenes
May 10, 2017·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Heath D SkinnerJohn V Heymach
Sep 15, 2017·Molecular Cancer Therapeutics·Marguerite L PalisoulKatherine C Fuh
Dec 5, 2018·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Toni M BrandDeric L Wheeler
Aug 11, 2018·Molecular Cancer Therapeutics·Nellie K McDanielDeric L Wheeler
May 23, 2020·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Nellie K McDanielDeric L Wheeler
Dec 22, 2020·Biochimica Et Biophysica Acta. Reviews on Cancer·Thomas ChabotFabrice Fleury
Dec 17, 2020·Cells·Pooja A ShahMitchell J Frederick
Apr 4, 2021·International Journal of Molecular Sciences·Marta Osrodek, Michal Wozniak

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.

Cell Migration

Cell migration is involved in a variety of physiological and pathological processes such as embryonic development, cancer metastasis, blood vessel formation and remoulding, tissue regeneration, immune surveillance and inflammation. Here is the latest research.

Carcinoma, Squamous Cell

Basal cell carcinoma is a form of malignant skin cancer found on the head and neck regions and has low rates of metastasis. Discover the latest research on basal cell carcinoma here.

Cell Migration in Cancer and Metastasis

Migration of cancer cells into surrounding tissue and the vasculature is an initial step in tumor metastasis. Discover the latest research on cell migration in cancer and metastasis here.

Cell Signaling by Tyrosine Kinases

Receptor tyrosine kinases (RTKs) are the high-affinity cell surface receptors for many polypeptide growth factors, cytokines, and hormones. RTKs have been shown not only to be key regulators of normal cellular processes but also to have a critical role in the development and progression of many types of cancer. Discover the latest research on cell signaling and RTK here.

© 2021 Meta ULC. All rights reserved